2017
Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions
Allen AM, Weinberger AH, Wetherill RR, Howe CL, McKee SA. Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions. Nicotine & Tobacco Research 2017, 21: 592-601. PMID: 29165663, PMCID: PMC6468133, DOI: 10.1093/ntr/ntx258.Peer-Reviewed Original ResearchConceptsSmoking-related outcomesOC useOral contraceptivesSmoking cessation outcomesCessation outcomesOC usersNovel smoking cessation interventionUse of OCsNicotine metabolismWeight gainSmoking-related symptomsEndogenous sex hormonesSmoking cessation interventionFaster nicotine metabolismCross-sectional studyPhysiological stress responsePremenopausal smokersCurrent smokingPremenopausal womenCessation interventionsCigarette smokingEstradiol levelsSex hormonesGreater oddsFollowing keywords
2014
Menopause and metabolic syndrome in obese individuals with binge eating disorder
Udo T, McKee SA, White MA, Masheb RM, Barnes RD, Grilo CM. Menopause and metabolic syndrome in obese individuals with binge eating disorder. Eating Behaviors 2014, 15: 182-185. PMID: 24854801, PMCID: PMC4032475, DOI: 10.1016/j.eatbeh.2014.01.003.Peer-Reviewed Original ResearchConceptsAge-matched menPostmenopausal womenPremenopausal womenMetabolic syndromeMetabolic abnormalitiesPoor glycemic controlElevated total cholesterolLow HDL levelsChronic medical conditionsHigh-risk populationSymptoms of BEDMetabolic functionsObese menObese womenBlood pressureGlycemic controlTotal cholesterolHDL levelsObese individualsMenopausal transitionGlucose levelsMedical conditionsEarly interventionTreatment studiesElevated levels
2010
Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion
Mazure CM, Toll B, McKee SA, Wu R, O’Malley S. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug And Alcohol Dependence 2010, 114: 68-72. PMID: 20832955, PMCID: PMC3016455, DOI: 10.1016/j.drugalcdep.2010.07.024.Peer-Reviewed Original ResearchConceptsMenstrual cycle phaseQuit datePoint prevalence abstinencePremenopausal womenBupropion SRFollicular phaseLuteal phaseAbsence of pharmacotherapySustained release bupropionOpen-label trialCycle phaseMechanism of actionRelease bupropionLabel trialNicotine replacementCessation interventionsOpen trialTreatment completionCessation outcomesContinuous abstinenceQuit dayGonadal hormonesTreatment periodAbstinence outcomesQuit attempts